The acute phase reactant orosomucoid-2 directly promotes rheumatoid inflammation
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Acute phase proteins involved in chronic inflammatory diseases have not been systematically analyzed. Here, global proteome profiling of serum and urine revealed that orosomucoid-2 (ORM2), an acute phase reactant, was differentially expressed in rheumatoid arthritis (RA) patients and showed the highest fold change. Therefore, we questioned the extent to which ORM2, which is produced mainly in the liver, actively participates in rheumatoid inflammation. Surprisingly, ORM2 expression was upregulated in the synovial fluids and synovial membranes of RA patients. The major cell types producing ORM2 were synovial macrophages and fibroblast-like synoviocytes (FLSs) from RA patients. Recombinant ORM2 robustly increased IL-6, TNF-α, CXCL8 (IL-8), and CCL2 production by RA macrophages and FLSs via the NF-κB and p38 MAPK pathways. Interestingly, glycophorin C, a membrane protein for determining erythrocyte shape, was the receptor for ORM2. Intra-articular injection of ORM2 increased the severity of arthritis in mice and accelerated the infiltration of macrophages into the affected joints. Moreover, circulating ORM2 levels correlated with RA activity and radiographic progression. In conclusion, the acute phase protein ORM2 can directly increase the production of proinflammatory mediators and promote chronic arthritis in mice, suggesting that ORM2 could be a new therapeutic target for RA.
Abstract
Acute phase proteins involved in chronic inflammatory diseases have not been systematically analyzed. Here, global proteome profiling of serum and urine revealed that orosomucoid-2 (ORM2), an acute phase reactant, was differentially expressed in rheumatoid arthritis (RA) patients and showed the highest fold change. Therefore, we questioned the extent to which ORM2, which is produced mainly in the liver, actively participates in rheumatoid inflammation. Surprisingly, ORM2 expression was upregulated in the synovial fluids and synovial membranes of RA patients. The major cell types producing ORM2 were synovial macrophages and fibroblast-like synoviocytes (FLSs) from RA patients. Recombinant ORM2 robustly increased IL-6, TNF-α, CXCL8 (IL-8), and CCL2 production by RA macrophages and FLSs via the NF-κB and p38 MAPK pathways. Interestingly, glycophorin C, a membrane protein for determining erythrocyte shape, was the receptor for ORM2. Intra-articular injection of ORM2 increased the severity of arthritis in mice and accelerated the infiltration of macrophages into the affected joints. Moreover, circulating ORM2 levels correlated with RA activity and radiographic progression. In conclusion, the acute phase protein ORM2 can directly increase the production of proinflammatory mediators and promote chronic arthritis in mice, suggesting that ORM2 could be a new therapeutic target for RA.
참고문헌 (45)
- Moshage, H., "Cytokines and the hepatic acute phase response", J. Pathol, 181, pp.257~266 (1997)
- Gabay, C., "Acute-phase proteins and other systemic responses to inflammation", N. Engl. J. Med, 340, pp.448~454 (1999)
- Hochepied, T., "Alpha(1)-acid glycoprotein:an acute phase protein with inflammatory and immunomodulating properties", Cytokine Growth Factor Rev, 14, pp.25~34 (2003)
- Pepys, M. B., "C-reactive protein : a critical update", J. Clin. Investig, 111, pp.1805~1812 (2003)
- Rodriguez, W., "Prevention and reversal of nephritis in MRL", lpr mice with a single injection of C-reactive protein, 2006, pp.54, 325~335
- Fang, Z., "C-reactive protein promotes the activation of fibroblast-like synoviocytes from patients with rheumatoid arthritis", Front. Immunol, 11, pp.958~ (2020)
- Lee, J. Y., "Serum amyloid A proteins induce pathogenic Th17 cells and promote inflammatory disease", Cell, 183, pp.2036~2039 (2020)
- Lee, M. S., "Serum amyloid A binding to formyl peptide receptor-like 1induces synovial hyperplasia and angiogenesis", J. Immunol, 177, pp.5585~5594 (2006)
- Rolla, S., "Acute-phase protein hemopexin is a negative regulator of Th17response and experimental autoimmune encephalomyelitis development", J. Immunol, 191, pp.5451~5459 (2013)
- Firestein, G. S., "Immunopathogenesis of rheumatoid arthritis", Immunity, 46, pp.183~196 (2017)
- Bartok, B., "Fibroblast-like synoviocytes : key effector cells in rheumatoid arthritis", Immunol. Rev, 233, pp.233~255 (2010)
- Bottini, N., "Duality of fibroblast-like synoviocytes in RA : passive responders and imprinted aggressors", Nat. Rev. Rheumatol, 9, pp.24~33 (2013)
- Kang, M. J., "Urinary proteome profile predictive of disease activity in rheu matoid arthritis", J. Proteome Res, 13, pp.5206~5217 (2014)
- Liu, S., "Fibrinogen-like protein 1 is a novel biomarker for predicting disease activity and prognosis of rheumatoid arthritis", Front. Immunol, 11, pp.579228~ (2020)
- Gu, Z., "Complex heatmaps reveal patterns and correlations in multidimensional genomic data", Bioinformatics, 32, pp.2847~2849 (2016)
- Aletaha, D., "2010 Rheumatoid arthritis classification criteria : an American College of Rheumatology", European League Against Rheumatism collaborative initiative, 2010, pp.62, 2569~2581
- Prevoo, M. L., "Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis", Arthritis Rheumatol, 38, pp.44~48 (1995)
- van der Heijde, D., "How to read radiographs according to the Sharp", van der Heijde method, 2000, pp.27, 261~263
- Giles, J. T., "Association of circulating adi ponectin levels with progression of radiographic joint destruction in rheumatoid arthritis", Ann. Rheum. Dis, 70, pp.1562~1568 (2011)
- Stark, C., "BioGRID : a general repository for interaction datasets", Nucleic Acids Res, 34, pp.D535~D539 (2006)
- Keshava Prasad, T. S., "Human protein reference database-2009 update", Nucleic Acids Res, 37, pp.D767~D772 (2009)
- Bovolenta, L. A., "HTRIdb: an open-access database for experimentally verified human transcriptional regulation interactions", BMC Genom, 13, pp.405~ (2012)
- Orchard, S., "The MIntAct project-IntAct as a common curation platform for 11 molecular interaction databases", Nucleic Acids Res, 42, pp.D358~D363 (2014)
- Szklarczyk, D., "STRING v10 : protein-protein interaction networks, integrated over the tree of life", Nucleic Acids Res, 43, pp.D447~D452 (2015)
- Staite, N. D., "Induction of an acute erosive monarticular arthritis in mice by interleukin-1 and methylated bovine serum albumin", Arthritis Rheum, 33, pp.253~260 (1990)
- Choi, S., "Transcription factor NFAT5 promotes macrophage survival in rheumatoid arthritis", J. Clin. Investig, 127, pp.954~969 (2017)
- Falconer, J., "Review : synovial cell metabolism and chronic inflammation in rheumatoid arthritis", Arthritis Rheumatol, 70, pp.984~999 (2018)
- O’Neill, L. A., "Targeting signal transduction as a strategy to treat inflammatory diseases", Nat. Rev. Drug Discov, 5, pp.549~563 (2006)
- Chang, S., "Molecular char acterization of erythrocyte glycophorin C variants", Blood, 77, pp.644~648 (1991)
- Croft, A. P., "Distinct fibroblast subsets drive inflammation and damage in arthritis", Nature, 570, pp.246~251 (2019)
- Bagchi, S., "In Situ Proximity Ligation Assay(PLA)", Methods Mol. Biol, 1318, pp.149~159 (2015)
- Brand, D. D., "Collagen-induced arthritis", Nat. Protoc, 2, pp.1269~1275 (2007)
- Yang, Y. H., "Dependence of interleukin-1-induced arthritis on granulocyte-macrophage colony-stimulating factor", Arthritis Rheumatol, 44, pp.111~119 (2001)
- Yoshimura, T., "The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?", Cell. Mol. Immunol, 15, pp.335~345 (2018)
- Phillipson, M., "The neutrophil in vascular inflammation", Nat. Med, 17, pp.1381~1390 (2011)
- Sun, Y., "Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis of Adult-Onset Still’s Disease", Front. Immunol, 11, pp.2112~ (2020)
- Elpek, G. O., "Orosomucoid in liver diseases", World J. Gastroenterol, 27, pp.7739~7747 (2021)
- Liu, Q., "Proteomic profiling for plasma biomarkers of tuberculosis progres sion", Mol. Med. Rep, 18, pp.1551~1559 (2018)
- Lobo, C. A., "Glycophorin C is the receptor for the Plasmodium falciparum erythrocyte binding ligand PfEBP-2(baebl)", Blood, 101, pp.4628~4631 (2003)
- King, M. J., "Reactivity with erythroid and non-erythroid tissues of a murine monoclonal antibody to a synthetic peptide having amino acid sequence com mon to cytoplasmic domain of human glycophorins C and D", Br. J. Haematol, 89, pp.440~448 (1995)
- Colin, Y., "Isolation of cDNA clones and complete amino acid sequence of human erythrocyte glycophorin C", J. Biol. Chem, 261, pp.229~233 (1986)
- Micieli, J. A., "Anti-glycophorin C induces mito chondrial membrane depolarization and a loss of extracellular regulated kinase 1", 2 protein kinase activity that is prevented by pretreatment with cytochalasin D : implications for hemolytic disease of the fetus and newborn caused by anti-Ge3, 2010, pp.50, 1761~1765
- Janciauskiene, S., "The multifaceted effects of alpha1-antitrypsin on neu trophil functions", Front. Pharmacol, 9, pp.341~ (2018)
- Luan, Y. Y., "The clinical significance and potential role of C-reactive protein in chronic inflammatory and neurodegenerative diseases", Front. Immunol, 9, pp.1302~ (2018)
- Bertaggia, E., "Haptoglobin is required to prevent oxidative stress and muscle atrophy", PLoS One, 9, pp.e100745~ (2014)